tiprankstipranks
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
US Market
Want to see COYA full AI Analyst Report?

Coya Therapeutics, Inc. (COYA) Financial Statements

118 Followers

Coya Therapeutics, Inc. Financial Overview

Coya Therapeutics, Inc.'s market cap is currently $95.47M. The company's EPS TTM is $-0.34; its P/E ratio is -4.25; Coya Therapeutics, Inc. is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 7.95M$ 3.55M$ 6.00M$ 0.00$ 0.00
Gross Profit$ 7.92M$ -8.31M$ 500.68K$ -4.41M$ 0.00
Operating Income$ -20.27M$ -17.25M$ -7.90M$ -9.81M$ -4.87M
EBITDA$ -20.24M$ -17.20M$ -7.33M$ -9.26M$ -4.85M
Net Income$ -21.23M$ -14.88M$ -7.99M$ -12.24M$ -4.89M
Balance Sheet
Cash & Short-Term Investments$ 46.82M$ 38.34M$ 32.63M$ 5.93M$ 4.34M
Total Assets$ 49.95M$ 44.35M$ 41.26M$ 8.40M$ 4.79M
Total Debt$ 0.00$ 0.00$ 0.00$ 12.97M$ 0.00
Net Debt$ -46.82M$ -38.34M$ -32.63M$ 7.03M$ -4.34M
Total Liabilities$ 6.92M$ 4.77M$ 5.63M$ 16.79M$ 1.15M
Stockholders' Equity$ 43.03M$ 39.58M$ 35.64M$ -8.39M$ 3.64M
Cash Flow
Free Cash Flow$ -10.74M$ -10.29M$ -11.19M$ -7.24M$ -4.04M
Operating Cash Flow$ -10.74M$ -10.29M$ -11.19M$ -7.24M$ -3.90M
Investing Cash Flow$ -1.16M$ -25.00K$ -543.19K$ -525.00K$ -136.80K
Financing Cash Flow$ 20.39M$ 16.03M$ 38.43M$ 9.36M$ -340.58K
Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History

Coya Therapeutics, Inc. Debt to Assets

Coya Therapeutics, Inc. Cash Flow

Coya Therapeutics, Inc. Forecast EPS vs Actual EPS